Skip to main navigation Skip to search Skip to main content

Adjuvant methotrexate (MTX) escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas

    Research output: Contribution to journal › Article › peer-review

    Original languageEnglish
    Pages (from-to)C-766
    JournalProceedings of the American Society of Clinical Oncology
    VolumeVol. 1
    StatePublished - 1982

    ASJC Scopus Subject Areas

    • General Medicine

    Cite this